{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Access to Novel Medical Products with Dr. Alison Bateman-House","description":"Providing patients access to novel medical products can be challenging to navigate for sponsors and trial participants alike.&amp;nbsp; To learn more about expanded access, compassionate use, Right to Try laws, I invited Dr. Alison\u200b \u200bBateman\u200b-\u200bHouse\u200b, \u200bPhD\u200b, \u200bMPH, MA\u200b, \u200ban\u200b \u200bAssistant\u200b \u200bProfessor\u200b \u200bin\u200b \u200bthe\u200b \u200bDivision\u200b \u200bof\u200b \u200bMedical Ethics\u200b \u200bat\u200b \u200bNYU\u200b \u200bGrossman\u200b \u200bSchool\u200b \u200bof\u200b \u200bMedicine\u200b.&amp;nbsp; Dr. \u200bBateman\u200b-\u200bHouse\u200b \u200bis\u200b \u200bco\u200b-\u200bchair \u200bof\u200b \u200bthe\u200b \u200bWorking\u200b \u200bGroup\u200b \u200bon Compassionate\u200b \u200bUse\u200b \u200band\u200b \u200bPreapproval\u200b \u200bAccess\u200b (\u200bCUPA\u200b), \u200ban\u200b \u200bacademic group\u200b \u200bthat\u200b \u200bstudies\u200b \u200bethical issues concerning access\u200b \u200bto\u200b \u200binvestigational\u200b \u200bmedical products\u200b \u200band which consists of patient advocates, clinicians, members of industry, current and former FDA staffers, lawyers, and academics, among others.&amp;nbsp; She advises biopharmaceutical companies, patient advocacy organizations, governmental, and non-governmental entities about clinical trial design and non-trial access programs, and she serves as ethicist for numerous data safety monitoring boards overseeing clinical trials.&amp;nbsp; She has published and spoken extensively on non-trial access to investigational medical products, \u200b\u200bequity in clinical\u200b \u200btrials\u200b\u200b, individualized therapeutics, \u200bthe\u200b \u200bhistory\u200b \u200band ethics\u200b \u200bof\u200b \u200busing\u200b \u200bhumans\u200b \u200bas\u200b \u200bresearch\u200b \u200bsubjects\u200b, and public health ethics.&amp;nbsp; Sponsor(s): This podcast is brought to you by Florence Healthcare. Florence eliminates chaotic workflows in clinical research operations with remote access and digital workflow platforms. More than 12,000 study sites, sponsors, and CROs in 45 countries trust them to accelerate their operations. To learn more, visit https:\/\/florencehc.com&amp;nbsp;  This podcast is brought to you by Slope. Slope drives operational excellence for highly complex, sample-intensive, early-phase clinical trials. The platform transforms chaotic clinical trial supply chains into protocol-specific operational workflows for sponsors, CROs, clinical research sites and labs. Learn more at https:\/\/www.slopeclinical.com\/    ","author_name":"Clinical Trial Podcast | Conversations with Clinical Research Experts","author_url":"https:\/\/clinicaltrialpodcast.com\/","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/28519829\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/163448834"}